Imatinib has been shown to prevent and reverse type I diabetes and reduce diabetes-induced atherosclerosis in mice with prediabetes or newly diagnosed diabetes, possibly through the inhibition of platelet-derived growth factor receptor (PDGFR) (38, 39). Here, PDGFRB is linked to diabetes mellitus.